Risk of hypovolemia associated with sodium–glucose cotransporter-2 inhibitors treatment: A meta-analysis of randomized controlled trials

AIM OF THE REVIEW: To assess the risk of hypovolemia for sodium–glucose cotransporter-2 (SGLT2) inhibitors treatment. METHOD: A systematic literature retrieval was performed in PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and Scopus from inception up to 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Rong, Xi, Zhu, Yawen, Wen, Bo, Liu, Kai, Li, Xinran, Gou, Qiling, Chen, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701837/
https://www.ncbi.nlm.nih.gov/pubmed/36451919
http://dx.doi.org/10.3389/fcvm.2022.973129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701837/
https://www.ncbi.nlm.nih.gov/pubmed/36451919
http://dx.doi.org/10.3389/fcvm.2022.973129

Ejemplares similares